Dr. Peter L. Zamfirescu Alexander, MD

Dr. Zamfirescu Alexander practices at Riverside Community Hospital in Riverside, California, part of HCA Healthcare.

Dr. Zamfirescu Alexander's NPI, 1548245830, was assigned on December 9, 2005. Dr. Zamfirescu Alexander graduated from Drexel University College Of Medicine in 1984. Dr. Zamfirescu Alexander holds California license G59612.

Dr. Zamfirescu Alexander's primary practice is Riverside Community Hospital, at 4445 Magnolia Avenue, Riverside, CA 92501 in Riverside County. The practice phone is (951) 788-3000.

Dr. Zamfirescu Alexander's primary practice is Riverside Community Hospital in Riverside, California, part of HCA Healthcare. The medical group on file is Pacific Pulmonary Medical Group. Dmand AI also links Dr. Zamfirescu Alexander to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Zamfirescu Alexander practices, 2 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Zamfirescu Alexander's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Zamfirescu Alexander is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Zamfirescu Alexander's licenses on file in 3 states: California, Idaho and Washington.

Dmand AI lists asthma, bronchitis, chronic obstructive pulmonary disease (COPD), chronic respiratory failure, chronic sinusitis, pulmonary fibrosis and tobacco use among the conditions Dr. Zamfirescu Alexander treats.

CMS data shows 1,194 Medicare services from Dr. Zamfirescu Alexander across 7 procedure codes in 2024, for 443 Medicare patients. Medicare paid $110,115 for them.

CMS counts 443 Medicare patients who saw Dr. Zamfirescu Alexander in 2024. The largest group is 65 to 74, with 192 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 59% are also on Medicaid. Their average risk score is 3.28, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Zamfirescu Alexander's median patient age at 67, with 52% women.

In 2024, Dr. Zamfirescu Alexander wrote 900 Medicare Part D claims for 173 patients. 59% of them were for generic drugs. CMS names the drug for 758 of them, across 21 drugs with 11 or more claims each, at $156,755 in total drug cost. In 2023, CMS named 849 claims across 24 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 74 out of 100 for Dr. Zamfirescu Alexander for performance year 2024, reported as part of a group. Dr. Zamfirescu Alexander accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 70 general payments to Dr. Zamfirescu Alexander from 20 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. GlaxoSmithKline, LLC. paid the most, $523.

Dmand AI lists 1 award for Dr. Zamfirescu Alexander, most recently NCQA PCMH in 2016.

Dr. Zamfirescu Alexander graduated from Drexel University College Of Medicine in 1984.

Dr. Zamfirescu Alexander is in network with 16 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.